Cytotoxic T-lymphocyte associated antigen 4 polymorphisms and asthma risk: A meta-analysis

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Nie, Wei ^a   Chen, Jiquan ^a   Xiu, Qingyu ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MUTATOR GENE; RISK FACTOR; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; ASTHMA; CHILD; CTLA-4 ANTIGEN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC;

EID: 84864856423     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042062     Document Type: Article

References (53)

1. Masoli M, Fabian D, Holt S, Beasley R, ((2004)) The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59:: 469--478.
2. Wilson DH, Adams RJ, Tucker G, Appleton S, Taylor AW, et al. ((2006)) Trends in asthma prevalence and population changes in South Australia, 1990-2003. Med J Aust 184:: 226--229.
3. Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH, ((2002)) Asthma: an epidemic of dysregulated immunity. Nat Immunol 3:: 715--720.
4. von Mutius E, ((2009)) Gene-environment interactions in asthma. J Allergy Clin Immun 123:: 3--11.
5. Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, et al. ((1987)) A new member of the immunoglobulin superfamily-CTLA-4. Nature 328:: 267--270.
6. Oosterwegel MA, Mandelbrot DA, Boyd SD, Lorsbach RB, Jarrett DY, et al. ((1999)) The role of CTLA-4 in regulating Th2 differentiation. J Immunol 163:: 2634--2639.
7. Alegre ML, Shiels H, Thompson CB, Gajewski TF, ((1998)) Expression and function of CTLA-4 in Th1 and Th2 cells. J Immunol 161:: 3347--3356.
8. Keane-Myers A, Gause WC, Linsley PS, Chen SJ, Wills-Karp M, ((1997)) B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J Immunol 158:: 2042--2049.
9. Padrid PA, Mathur M, Li X, Herrmann K, Qin Y, et al. ((1998)) CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma. Am J Respir Cell Mol Biol 18:: 453--462.
10. Van Oosterhout A, Hofstra C, Shields R, Chan B, Van Ark I, et al. ((1997)) Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma. Am J Respir Cell Mol Biol 17:: 386--392.
11. Deurloo DT, Van Esch B, Hofstra CL, Nijkamp FP, van Oosterhout AJM, ((2001)) CTLA4-IgG reverses asthma manifestations in a mild but not in a more "severe" ongoing murine model. Am J Respir Cell Mol Biol 25:: 751--760.
12. Choi JM, Ahn MH, Chae WJ, Jung YG, Park JC, et al. ((2006)) Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation. Nat Med 12:: 574--579.
13. Lin KW, Jen KY, Suarez CJ, Crouch EC, Perkins DL, et al. ((2010)) Surfactant protein D-mediated decrease of allergen-induced inflammation is dependent upon CTLA4. J Immunol 184:: 6343--6349.
14. Ueda H, Howson JMM, Esposito L, Heward J, Snook GC, et al. ((2003)) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:: 506--511.
15. Hizawa N, Yamaguchi E, Jinushi E, Konno S, Kawakami Y, et al. ((2001)) Increased total serum IgE levels in patients with asthma and promoter polymorphisms at CTLA4 and FCER1B. J Allergy Clin Immunol 108:: 74--79.
16. Howard TD, Postma DS, Hawkins GA, Koppelman GH, Zheng SL, et al. ((2002)) Fine mapping of an IgE-controlling gene on chromosome 2q: Analysis of CTLA4 and CD28. J Allergy Clin Immunol 110:: 743--751.
17. Lee SY, Lee YH, Shin C, Shim JJ, Kang KH, et al. ((2002)) Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. Chest 122:: 171--176.
18. Iharaa FNK, Sasakia SAY, Nishimab KKATS, Haraa T, ((2000)) Lack of association between CD28/CTLA-4 gene polymorphisms and atopic asthma in the Japanese population. Exp Clin Immunogenet 17:: 179--184.
19. Heinzmann A, Plesnar C, Kuehr J, Forster J, Deichmann K, ((2000)) Common polymorphisms in the CTLA-4 and CD28 genes at 2q33 are not associated with asthma or atopy. Eur J Immunogenet 27:: 57--61.
20. Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, et al. ((2005)) Systematic review and meta-analysis of the association between β2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 162:: 201--211.
21. Li Y, Guo B, Zhang L, Han J, Wu B, et al. ((2008)) Association between C-589T polymorphisms of interleukin-4 gene promoter and asthma: a meta-analysis. Respir Med 102:: 984--992.
22. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J, ((2005)) A method for meta-analysis of molecular association studies. Statist Med 24:: 1291--1306.
23. Begg CB, Mazumdar M, ((1994)) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:: 1088--1101.
24. Egger M, Smith GD, Schneider M, Minder C, ((1997)) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:: 629--634.
25. Sohn MH, Kim SH, Song TW, Kim KW, Kim ES, et al. ((2007)) Cytotoxic T lymphocyte-associated antigen-4 gene polymorphisms confer susceptibility to atopic asthma in Korean children. Pediatr Pulmonol 42:: 542--547.
26. Oh KY, Kang MJ, Choi WA, Kwon JW, Kim BJ, et al. ((2010)) Association Between Serum IgE Levels and the CTLA4 +49A/G and FCER1B -654C/T Polymorphisms in Korean Children With Asthma. Allergy Asthma Immunol Res 2:: 127--133.
27. Nakao F, Ihara K, Ahmed S, Sasaki Y, Kusuhara K, et al. ((2000)) Lack of association between CD28/CTLA-4 gene polymorphisms and atopic asthma in the Japanese population. Exp Clin Immunogenet 17:: 179--184.
28. Jasek M, Luszczek W, Obojski A, Winiarska B, Halubek K, et al. ((2006)) Distribution of CTLA-4 polymorphisms in allergic asthma. Int Arch Allergy Immunol 141:: 223--229.
29. Chan IH, Tang NL, Leung TF, Huang W, Lam YY, et al. ((2008)) Study of gene-gene interactions for endophenotypic quantitative traits in Chinese asthmatic children. Allergy 63:: 1031--1039.
30. Berce V, Potocnik U, ((2010)) Functional polymorphism in CTLA4 gene influences the response to therapy with inhaled corticosteroids in Slovenian children with atopic asthma. Biomarkers 15:: 158--166.
31. Schubert K, Von Bonnsdorf H, Burke M, Ahlert I, Braun S, et al. ((2006)) A comprehensive candidate gene study on bronchial asthma and juvenile idiopathic arthritis. Dis Markers 22:: 127--132.
32. Qian L, Lu JR, Jin YL, ((2006)) Relationship between polymorphism of cytotoxic T lymphocyte associated antigen gene promoter -318 C/T and serum total IgE level. J Clin Pediatr 25:: 660--663.
33. Daley D, Lemire M, Akhabir L, Chan-Yeung M, He JQ, et al. ((2009)) Analyses of associations with asthma in four asthma population samples from Canada and Australia. Hum Genet 125:: 445--459.
34. Undarmaa S, Mashimo Y, Hattori S, Shimojo N, Fujita K, et al. ((2010)) Replication of genetic association studies in asthma and related phenotypes. J Hum Genet 55:: 342--349.
35. DeWan AT, Triche EW, Xu XM, Hsu LI, Zhao C, et al. ((2010)) PDE11A associations with asthma: results of a genome-wide association scan. J Allergy Clin Immunol 126:: 871--873.
36. Sleiman PMA, Flory J, Imielinski M, Bradfield JP, Annaiah K, et al. ((2010)) Variants of DENND1B associated with asthma in children. N Engl J Med 362:: 36--44.
37. Noguchi E, Sakamoto H, Hirota T, Ochiai K, Imoto Y, et al. ((2011)) Genome-wide association study identifies HLA-DP as a susceptibility gene for pediatric asthma in Asian populations. PLoS Genet 7 (7):: e1002170.
38. Anantharaman R, Andiappan AK, Nilkanth PP, Suri BK, Wang DY, et al. ((2011)) Genome-wide association study identifies PERLD1 as asthma candidate gene. BMC Med Genet 12:: 170--182.
39. Ligers A, Teleshova N, Masterman T, Huang W, Hillert J, ((2001)) CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2:: 145--152.
40. Nisticò L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, et al. ((1996)) The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 5:: 1075--1080.
41. Sun T, Zhou Y, Yang M, Hu Z, Tan W, et al. ((2008)) Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res 68:: 7025--7034.
42. Kavvoura FK, Akamizu T, Awata T, Ban Y, Chistiakov DA, et al. ((2007)) Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J Clin Endocrinol Metab 92:: 3162--3170.
43. Muñoz-Valle JF, Valle Y, Padilla-Gutiérrez JR, Parra-Rojas I, Rangel-Villalobos H, et al. ((2010)) The+49A>G CTLA-4 polymorphism is associated with rheumatoid arthritis in Mexican population. Clin Chim Acta 411:: 725--728.
44. Miyake Y, Ikeda F, Takaki A, Nouso K, Yamamoto K, ((2011)) +49A/G polymorphism of cytotoxic T-lymphocyte antigen 4 gene in type 1 autoimmune hepatitis and primary biliary cirrhosis: A meta-analysis. Hepatol Res 41:: 151--159.
45. Munthe-Kaas MC, Hakon Carlsen K, Helms PJ, Gerritsen J, Whyte M, et al. ((2004)) CTLA-4 polymorphisms in allergy and asthma and the T(H)1/T (H)2 paradigm. J Allergy Clin Immunol 114:: 280--287.
46. Yang KD, Liu CA, Chang JC, Chuang H, Ou CY, et al. ((2004)) Polymorphism of the immune-braking gene CTLA-4 (+49) involved in gender discrepancy of serum total IgE levels and allergic diseases. Clin Exp Allergy 34:: 32--37.
47. Jones G, Wu S, Jang N, Fulcher D, Hogan P, et al. ((2006)) Polymorphisms within the CTLA4 gene are associated with infant atopic dermatitis. Br J Dermatol 154:: 467--471.
48. Park K, Baek J, Do J, Bang D, Lee ES, ((2009)) CTLA4 gene polymorphisms and soluble CTLA4 protein in Behcet's disease. Tissue Antigens 74:: 222--227.
49. Qin XJ, Shi HZ, Qin SM, Kang LF, Huang CP, et al. ((2005)) Effects of allergen inhalation and oral glucocorticoid on serum soluble CTLA-4 in allergic asthmatics. Allergy 60:: 774--779.
50. Shi HZ, Mo XY, Zhong XN, ((2005)) Soluble CTLA-4 in sera of patients with bronchial asthma. J Asthma 42:: 133--139.
51. Wong CK, Lun S, Ko F, Ip W, Hui D, et al. ((2005)) Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma. Clin Exp Immunol 141:: 122--129.
52. Ip W, Wong CK, Leung T, Lam C, ((2006)) Plasma concentrations of soluble CTLA-4, CD28, CD80 and CD86 costimulatory molecules reflect disease severity of acute asthma in children. Pediatr Pulmonol 41:: 674--682.
53. Thornton A, Lee P, ((2000)) Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol 53:: 207--216.